The Extent and Growth of Prior Authorization in Medicare Advantage

被引:4
|
作者
Neprash, Hannah T. [1 ]
Mulcahy, John F. [1 ]
Golberstein, Ezra [1 ]
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, 420 Delaware St SE,MMC 729, Minneapolis, MN 55455 USA
来源
AMERICAN JOURNAL OF MANAGED CARE | 2024年 / 30卷 / 03期
关键词
D O I
10.37765/ajmc.2024.89519
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVES: To assess trends in the use of prior authorization requirements among Medicare Advantage (MA) plans. STUDY DESIGN: Descriptive quantitative analysis. METHODS: Data were from the CMS MA benefit and enrollment files for 2009-2019, supplemented with area-level data on demographic and provider market characteristics. For each service category, we calculated the annual share of MA enrollees in plans requiring at least some prior authorization and plotted trends over time. We mapped the county-level share of MA enrollees exposed to prior authorization in 2009 vs 2019. We quantified the association between local share of MA enrollees exposed to prior authorization and characteristics of that county in the same year. Finally, we plotted the share of MA enrollees exposed to prior authorization requirements over time for the 6 largest MA carriers. RESULTS: From 2009 to 2019, the share of MA enrollees in plans requiring prior authorization for any service remained stable. By service category, the share of MA enrollees exposed to prior authorization ranged from 30.7% (physician specialist services) to 72.2% (durable medical equipment) in 2019, with most service categories requiring prior authorization more often over time. Several area-level demographic and provider market characteristics were associated with prior authorization requirements, but these associations weakened over time. The use of prior authorization varied widely across plans. CONCLUSIONS: In 2019, roughly 3 in 4 MA enrollees were in a plan requiring prior authorization. Service-level, area-level, and carrier-level patterns suggest a wide range of approaches to prior authorization requirements.
引用
收藏
页码:E85 / E92
页数:14
相关论文
共 50 条
  • [1] Improving Prior Authorization in Medicare Advantage
    Anderson, Kelly E.
    Darden, Michael
    Jain, Amit
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (15): : 1497 - 1498
  • [2] Rule Tackles Medicare Advantage Marketing, Prior Authorization
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (18): : 1543 - 1543
  • [3] Medicare Advantage Prior Authorization Requirements for Otolaryngologic Procedures in 2021
    Miller, Lauren E.
    Miller, Ashley L.
    Rocco, James W.
    Rathi, Vinay K.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 171 (05) : 1601 - 1604
  • [4] VARIATIONS IN MEDICARE ADVANTAGE PRIOR AUTHORIZATION POLICIES FOR HIGH-COST ONCOLOGY IMMUNOTHERAPIES
    Dardouri, M.
    Presskreischer, R. M.
    Zemplenyi, A.
    Anderson, K. E.
    VALUE IN HEALTH, 2023, 26 (06) : S224 - S224
  • [5] Comparison of prior authorization across insurers: cross sectional evidence from Medicare Advantage
    Gupta, Ravi
    Fein, Jay
    Newhouse, Joseph P.
    Schwartz, Aaron L.
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 384
  • [6] Medicare Advantage Has Become Notorious for Prior Authorization-CMS and Lawmakers Are Taking Action
    Cahan, Eli
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (12): : 948 - 951
  • [7] Evaluation of Prior Authorization in Medicare Nonemergent Ambulance Transport
    Contreary, Kara
    Asher, Andrew
    Coopersmith, Jared
    JAMA HEALTH FORUM, 2022, 3 (07): : E222093
  • [8] Prior Authorization, Quantity Limits, and Costs for Varenicline in Medicare
    Jiang, Changchuan
    Nipp, Ryan D.
    Hong, Arthur S.
    Shih, Ya-Chen Tina
    Xing, Jiazhang
    Mullins, Megan A.
    Yabroff, K. Robin
    Liao, Joshua M.
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [9] Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population
    Ferries, Erin
    Racsa, Patrick
    Bizzell, Brock
    Rhodes, Clay
    Suehs, Brandon
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (05): : 596 - 606
  • [10] Characteristics of Prior Authorization Policies for NewDrugs in Medicare Part D
    Naci, Huseyin
    Forrest, Robin
    Zhai, Mike
    Stofesky, Amanda R.
    Kesselheim, Aaron S.
    JAMA HEALTH FORUM, 2023, 4 (02): : E225610